Literature DB >> 20717966

Expression of micro-RNA-145 is regulated by a highly conserved genomic sequence 3' to the pre-miR.

Gaspare La Rocca1, Bin Shi, Laura Sepp-Lorenzino, Renato Baserga.   

Abstract

Micro-RNA-145 (miR145), a tumor suppressor miR, dramatically inhibits growth of cancer cells in culture and plays a significant role in human stem cells differentiation. We have isolated a human genomic sequence of 864 bp comprising the pre-miR and its flanking sequences. The cloned miR145 genomic sequence expresses a mature miR145 in transfected cells. We show here that flanking sequences on either side of the pre-miR sequence can modulate its expression levels. Surprisingly, a highly conserved sequence 3' to the pre-miR plays a crucial role in miR145 expression.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20717966     DOI: 10.1002/jcp.22368

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells.

Authors:  Xiaochun Long; Joseph M Miano
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

2.  Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.

Authors:  Zhou Xu; Xingruo Zeng; Jiawei Xu; Derek Xu; Jingxia Li; Honglei Jin; Guosong Jiang; Xiaosi Han; Chuanshu Huang
Journal:  Neuro Oncol       Date:  2015-12-17       Impact factor: 12.300

3.  Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.

Authors:  Guosong Jiang; Chao Huang; Jingxia Li; Haishan Huang; Honglei Jin; Junlan Zhu; Xue-Ru Wu; Chuanshu Huang
Journal:  Mol Cancer Ther       Date:  2017-02-21       Impact factor: 6.261

4.  Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.

Authors:  Xingruo Zeng; Zhou Xu; Jiayan Gu; Haishan Huang; Guangxun Gao; Xiaoru Zhang; Jingxia Li; Honglei Jin; Guosong Jiang; Hong Sun; Chuanshu Huang
Journal:  Mol Cancer Ther       Date:  2016-02-01       Impact factor: 6.261

5.  Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.

Authors:  Xiaojun Liu; Yunhui Cheng; Jian Yang; Shanshan Qin; Xiuwei Chen; Xiaojun Tang; Xiangyu Zhou; Thomas J Krall; Chunxiang Zhang
Journal:  J Am Heart Assoc       Date:  2013-10-28       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.